NEXO
20+ leading crypto organizations including BTC Inc, Bitget, Brink, Chainalysis, Hacken, Nansen, and Unstoppable Domains have come together for the 'Bitcoin Deserves an Emoji' movement, initiated by Nexo. Uniting the global crypto community, the initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312299831/en/
Uniting the global crypto community, the 'Bitcoin Deserves an Emoji' initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society. (Graphic: Business Wire)
This community-driven initiative starts with a 50-day petition on Change.org, followed by an official proposal to the Unicode Consortium during the 2024 submission window. The new, widespread effort for a Bitcoin emoji, once turned down in 2020, shows just how important blockchain has become in our daily lives.
Celebrating Community, Culture, and Collective Values
92% of internet users worldwide use emojis in their digital communications, according to Unicode. Originating in Japan in the 1990s, emojis have transformed from niche pictographs to key elements of online conversations, transcending language and borders to reflect our values, innovations, and contemporary culture. Similarly, Bitcoin, beyond being a mere asset, displays the technological breakthrough of blockchain, embodying principles of decentralization, transparency, and security. Its inclusion as an emoji would not only symbolize its indispensable role in today's digital and financial landscapes but also ensure Bitcoin is recognized as an integral part of daily life across the globe.
Voices of the Movement
Already gaining substantial traction, the Bitcoin Emoji Initiative showcases the unity within the cryptocurrency community and the shared goal of further establishing Bitcoin's presence in our cultural landscape.
“Bitcoin's journey reflects a remarkable blend of innovation and community. It's time its significance is recognized universally, starting with a symbol we all understand - an emoji. Join us in making history,” said Kosta Kantchev, Co-founder & Executive Chairman of Nexo.
“Bitcoin is universal money for the world, it needs a universal emoji for every person, young and old to use,” said David Bailey, CEO of BTC Inc.
“Supporting Bitcoin's development has always been about changing the world through code. An official emoji is a nod to Bitcoin's technological impact on the world.” said Mike Schmidt, Executive Director of Brink.
"Bitget recognizes the significance of having a Bitcoin emoji as a universal symbol of digital assets in our everyday communication. This initiative aligns with our mission to promote crypto adoption and accessibility. We wholeheartedly support this endeavor and believe it will contribute further to mainstream acceptance of the whole industry. Together with our partners and the wider crypto community, we are committed to advocating for the inclusion of a Bitcoin emoji on keyboards worldwide,” said Gracy Chen, Managing Director of Bitget.
"We fully support Nexo's petition as this initiative to create a Bitcoin Emoji aligns perfectly with Nansen's commitment to fostering a more inclusive and expressive crypto environment”, said Alex Svanevik, CEO and co-founder of Nansen.
“For a decade, Chainalysis has been dedicated to fostering trust in blockchains while aiding the advancement of the web3 ecosystem and assisting public sector entities in staying abreast of crypto developments. As a trailblazer in blockchain analysis, we've safeguarded and championed Bitcoin since its inception. We commend Nexo's advocacy for acknowledging a cultural symbol—the Bitcoin emoji—a testament to the era we inhabit”, said Ian Andrews, CMO of Chainalysis.
"The definition of an emoji is a small digital image or icon used to express an idea. Bitcoin is now a well-known idea across all countries. CryptoQuant fully supports Nexo's initiative to facilitate the global mass adoption of Bitcoin," said CryptoQuant's CEO Ki Young Ju.
“The Bitcoin emoji reflects the essence of decentralization, representing a collective movement towards a more open and inclusive financial future for everyone. We align with Nexo's Bitcoin Emoji petition,” said Sam Lekhak, Head of Marketing & Comms at Liquity.
“We're thrilled to stand alongside industry leaders in championing a Bitcoin emoji, a move poised to give identity to the industry while also serving as a bridge between technical innovation and cultural expression,” said Sandy Carter, COO, Unstoppable Domains
Join the Movement
Everyone is invited to be part of this historic community-driven initiative. By signing the Change.org petition and advocating for the Bitcoin emoji, everyone can contribute to celebrating Bitcoin's legacy and future. For more information and to join the campaign, visit bitcoinemoji.org.
About the Initiative
This initiative is a collaborative effort by 20+ leading organizations in the cryptocurrency space, united by a common goal to promote understanding, adoption, and technological progress of digital currencies. Participating organizations: Nexo, Brink, Bitget, Chainalysis, Polygon, Brave, BTC Inc, Hacken, CryptoQuant, Nansen, Unstoppable Domains, Liquity, Mara, Busha, Zulu, Cadenza, Bware Labs, Meta4 Capital, Sift, MarketAcross, Bitcompare, Bithomp, Milkroad, Crypto Oasis.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312299831/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release
Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom